News & Articles
Sequential photothermal flow chemistry delivers high yields of bicyclic lactams
Researchers at the University of Bristol have successfully prepared bicyclic lactams in high yield and excellent purity, using a photochemical [2+2] cycloaddition followed by a thermal electrocyclic cascade
Laser-etched bottom rack ID improves sample traceability
Micronic announces the addition of a 2D Data-Matrix code on the bottom of Micronic ULT Racks
Self-harm may be increasing more quickly among young people from ethnic minorities
The rates of self-harm could be rising more quickly in children and adolescents from ethnic minority groups than in those from white groups, according to a study led by University of Manchester researchers
Takara Bio Europe AB and Boston IVF Fertility Center announce partnership
The collaboration will enable the derivation of clinical-grade hES cell lines for cell therapy applications
University of Oxford and Oracle Cloud System helping researchers identify COVID-19 variants faster
The genomic sequencing platform facilitates the discovery and action of new, potentially harmful coronavirus mutations worldwide
Baby therapy boosts social development, reducing clinical autism diagnosis by two-thirds
These findings are the first evidence that a pre-emptive intervention during infancy could lead to a child falling below the threshold for a clinical diagnosis of autism
Astronomers solve 900-year-old cosmic mystery
Origins of 1181AD Chinese supernova have now been revealed
HORIBA scientific announces a new partnership with Covalent Metrology
North American Demo Lab will expand Covalent’s chemical analysis services and showcase HORIBA’s analytical instrumentation
Study links childhood exposure to air pollution and self-harm in later life
A study has revealed a link between higher levels of exposure to two common pollutants during childhood and an increased risk of self-harm in later life
GammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for the treatment of acute myeloid leukemia
First dose delivered to patients in a multi-center U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy
Indica Labs earns work/life flexibility award
For the second year running, Indica Labs has been named a top workplace by the Albuquerque Journal
Indica Labs announces launch of cloud-based digital pathology deployment at NCI
Indica Labs is pleased to announce the formal launch of its software within the National Cancer Institute (NCI)
Novel polymer can boost performance of organic and perovskite solar cells
Skoltech researchers have synthesized a new conjugated polymer for organic electronics using two different chemical reactions
INTEGRA automated pipetting solutions assist antibiotic development
Discover how INTEGRA pipetting systems can streamline routine pipetting tasks for more efficient and productive workflows in antibiotic development
Study reveals COVID-19 vaccine response in patients with impaired immune systems
A large proportion of patients with impaired immune systems mount a low, or undetectable, immune response after two doses of COVID-19 vaccine
Covid-19 booster jab in the autumn will offer better protection against variants of concern, suggests new study
Scientists are recommending that a ‘booster’ dose of the Covid-19 vaccine can protect against variants
Covid-19 infection presents considerably higher blood clot risks over vaccination
Researchers announce the results of a study into thrombocytopenia and thromboembolic events following Covid-19 vaccination
Key considerations in automated nucleic acid extraction for pathogen and genetic screening workflows
Join experts Dr. Catherine Goh and Dr. Uwe Jaentges to learn how to avoid the 7 deadly sins of DNA/RNA extractions
Smiling can build relationships even after someone has been untrustworthy, researchers find
A certain type of smile can help to restore trust in relationships after someone has been uncooperative or untrustworthy, according to new research by Queen’s University Belfast
Double vaccination halves risk of long COVID
Adults who have received a double vaccination are 47% less likely to have long COVID
RedHill Biopharma's opaganib demonstrates strong inhibition of COVID-19 Delta variant
Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cell model
























